Improvement Effect of Soyeom Pharmacopuncture on Gout via NLRP3 Inflammasome Regulation |
Sung Wook Kim
(Department of Korean Medicine, College of Korean Medicine, Woosuk University)
Jun Ho Lee (Department of Korean Medicine, College of Korean Medicine, Woosuk University) Hyeonjin Kim (Department of Korean Medicine, College of Korean Medicine, Woosuk University) Seong Hoon Lee (Department of Korean Medicine, College of Korean Medicine, Woosuk University) Dajeong Jeong (Department of Korean Medicine, College of Korean Medicine, Woosuk University) Hyuk Soon Kim (Department of Biomedical Sciences, College of Natural Science and Department of Health Sciences, The Graduate School of Dong-A University) Cheol-Jung Lee (Research Center for Materials Analysis, Korea Basic Science Institute) Dae Yong Kim (Department of Korean Medicine, College of Korean Medicine, Woosuk University) Tae Han Yook (Department of Korean Medicine, College of Korean Medicine, Woosuk University) Gabsik Yang (Department of Korean Medicine, College of Korean Medicine, Woosuk University) |
1 | Martinon F, Glimcher LH. Gout: new insights into an old disease. J Clin Invest. 2006;116(8):2073-5. DOI |
2 | Ozenver N, Efferth T. Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases. Pharmacol Res. 2021;170:105710. |
3 | Wortmann M, Klotz R, Kalkum E, Dihlmann S, Bockler D, Peters AS. Inflammasome targeted therapy as novel treatment option for aortic aneurysms and dissections: a systematic review of the preclinical evidence. Front Cardiovasc Med. 2022;8:805150. |
4 | Rider TG, Jordan KM. The modern management of gout. Rheumatology (Oxford). 2010;49(1):5-14. DOI |
5 | Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021;397(10287):1843-55. DOI |
6 | Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum. 1995;38(5):628-32. DOI |
7 | Choi HK, Mount DB, Reginato AM; American College of Physicians; American Physiological Society. Pathogenesis of gout. Ann Intern Med. 2005;143(7):499-516. DOI |
8 | Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54(8):2688-96. DOI |
9 | Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout. Nat Rev Dis Primers. 2019;5(1):69. |
10 | Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332(7553):1302-8. DOI |
11 | McKenzie BJ, Wechalekar MD, Johnston RV, Schlesinger N, Buchbinder R. Colchicine for acute gout. Cochrane Database Syst Rev. 2021;8(8):CD006190. |
12 | Yook TH. Clinical observation about the extent of improvement of low back pain patient through medi-acupuncture therapy. J Korean Orient Med Soc. 1995;16(1):184-97. |
13 | Rees F, Hui M, Doherty M. Optimizing current treatment of gout. Nat Rev Rheumatol. 2014;10(5):271-83. DOI |
14 | So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13(11):639-47. DOI |
15 | Yang G, Yeon SH, Lee HE, Kang HC, Cho YY, Lee HS, et al. Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation. Rheumatology (Oxford). 2018;57(4):727-36. DOI |
16 | Yang G, Lee HE, Moon SJ, Ko KM, Koh JH, Seok JK, et al. Direct binding to NLRP3 pyrin domain as a novel strategy to prevent NLRP3-driven inflammation and gouty arthritis. Arthritis Rheumatol. 2020;72(7):1192-202. |
17 | Richette P, Bardin T. Should prednisolone be first-line therapy for acute gout? Lancet. 2008;372(9646):1301; author reply 1301-2. |
18 | Groff GD, Franck WA, Raddatz DA. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum. 1990;19(6):329-36. |
19 | Lee KH, Cho YY, Kim S, Sun SH. History of research on pharmacopuncture in Korea. J Pharmacopuncture. 2016;19(2):101-8. DOI |
20 | Bang M, Chang S, Kim JH, Min SY. Pharmacopuncture for asthma: a systematic review and a meta-analysis of randomized controlled trials. Eur J Integr Med. 2017;11:6-17. DOI |
21 | Wang JQ, Li XW, Liu M, Wang SC, Cao ZF. Inhibitory effect of Zanthoxylum bungeanum seed oil on ovalbumin-induced lung inflammation in a murine model of asthma. Mol Med Rep. 2016;13(5):4289-302. DOI |
22 | Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328. |
23 | Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821-32. DOI |
![]() |